Capstan Therapeutics
Steven M. Albelda, M.D., is the William Maul Measey Professor of Medicine, Director of the Thoracic Oncology Research Laboratory, and co-Director of the Translational Center of Excellence for Lung Cancer. Dr. Albelda has led an NCI-funded Program Project aimed at developing immune-gene therapy for thoracic cancers for the past 22 years, resulting in a series of Phase 1 and 2 clinical trials for patients with mesothelioma and lung cancer. The major areas of recent interest in the lab have been augmentation of anti-tumor immune effects, adoptive T cell transfer, and characterization and modulation of the tumor microenvironment.
This person is not in the org chart
This person is not in any offices
Capstan Therapeutics
2 followers
Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.